If protesters were aware of the extent to which those with life-threatening medi...
The necessary roughness of 2023 has set up a very promising 2024 for the biotech...
The endocannabinoid inhibitor SYT-510 will be investigated in healthy patients t...
The AI Governance Alliance has called for stronger collaboration to create a fra...
The layoffs will free cash resources that will extend financial runways and focu...
Information gathered from the study will guide an upcoming two-week mission sche...
Delayed diagnoses in many Gaucher disease patients contribute to slower-than-opt...
Ikena has also paused exploratory research and discovery in addition to workforc...
The US FDA has declined to grant approval for Satsuma Pharmaceuticals’ STS101 fo...
The US FDA has granted fast track designation for Verastem’s avutometinib for tr...
BridgeBio Pharma has secured strategic financing of $1.25bn from Blue Owl Capita...
Japan has approved argenx’s VYVDURA injection for subcutaneous administration to...
Timothy Stenzel, who led the FDA's diagnostics division during the Covid-19 pand...
A key U.S. lawmaker is urging six large drug companies to remove dozens of paten...
This week on "The Readout LOUD" podcast: Why are rich biotechs cutting costs? Ha...
Lawmakers are headed toward passage of a stopgap spending bill that funds the sa...
